This inventor holds 1 USPTO granted patent. Top assignee: Ambrx, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Lillian Skidmore: Innovator in FGF-21 Research
Introduction
Lillian Skidmore (Nee Ho) is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of innovative methods related to FGF-21 mutants. Her work has implications for various therapeutic applications.
Latest Patents
Lillian holds 1 patent for her invention titled "Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives." This patent focuses on modified FGF-21 polypeptides and their uses, showcasing her expertise in protein engineering and therapeutic development.
Career Highlights
Lillian is currently associated with Ambrx, Inc., a company known for its advancements in protein therapeutics. Her role at Ambrx has allowed her to further her research and contribute to groundbreaking innovations in the field.
Collaborations
Throughout her career, Lillian has collaborated with notable colleagues, including Thomas P Cujec and Vadim Kraynov. These partnerships have enhanced her research and expanded the impact of her work in biotechnology.
Conclusion
Lillian Skidmore is a trailblazer in the field of FGF-21 research, with a patent that highlights her innovative approach to biotechnology. Her contributions continue to influence the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile